cro.directory
← Compare landing

Indero vs Quanticate

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/inderocro/quanticate

CategoryInderoQuanticate
Listed sitecrocro
SummaryIndero is a dual-focus CRO specializing in dermatology and rheumatology clinical trials, offering end-to-end services from early to late phase with global capabilities across North America, Europe, Latin America, and Asia-Pacific.Quanticate is a biometrics CRO with 30 years of expertise in biostatistics, clinical data management, and pharmacovigilance across all clinical trial phases. The company specializes in statistical protocol design, CDISC standards compliance, and real-world data analysis to support regulatory submissions.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • Translational Research
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Clinical Operations
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
ModalitiesData not yet provided.Data not yet provided.
Indications
  • Dermatology
  • Immunology
Data not yet provided.
LocationsData not yet provided.
  • Headquarters, Hitchin, Hertfordshire, United Kingdom
  • Raleigh, Raleigh, North Carolina, United States
  • Warsaw, Warsaw, Poland
  • Bloemfontein, Bloemfontein, South Africa
  • Bangalore, Bangalore, India
  • Hyderabad, Hyderabad, Telangana, India
  • Manchester, Wilmslow, Cheshire, United Kingdom
  • Toronto, Mississauga, Ontario, Canada
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.